Patient Square Capital LP Portfolio Holdings

Patient Square Capital LP

  • $242 Billion
  • Q1 2025

Patient Square Capital LP has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $242 Billion distributed in 19 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $126B, Insmed Inc with a value of $25.2B, Liquidia Corp with a value of $22.5B, Eye Point Pharmaceuticals, Inc. with a value of $8.03B, and Ocular Therapeutix, Inc with a value of $6.75B.

Examining the 13F form we can see an decrease of $25.7B in the current position value, from $267B to 242B.

Patient Square Capital LP is based out at Menlo Park, CA

Below you can find more details about Patient Square Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $242 Billion
Healthcare: $231 Billion

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 19
  • Current Value $242 Billion
  • Prior Value $267 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 14, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 4 stocks
  • Additional Purchases 12 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Patient Square Capital LP Portfolio

Follow Patient Square Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patient Square Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Patient Square Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email